Nexalis Therapeutics (ASX:NX1) Total Assets: A$1.21 Mil (As of Dec. 2025)


What is Nexalis Therapeutics Total Assets?

Nexalis Therapeutics ASX:NX1 Total Assets is A$1.21 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Nexalis Therapeutics's Total Assets for the quarter that ended in Dec. 2025 was A$1.21 Mil.

During the past 12 months, Nexalis Therapeutics's average Total Assets Growth Rate was 49.10% per year. During the past 3 years, the average Total Assets Growth Rate was 70.00% per year. During the past 5 years, the average Total Assets Growth Rate was 42.50% per year.

During the past 10 years, Nexalis Therapeutics's highest 3-Year average Total Assets Growth Rate was 70.00%. The lowest was -45.50%. And the median was 14.80%.

Total Assets is connected with ROA %. Nexalis Therapeutics's annualized ROA % for the quarter that ended in Dec. 2025 was -115.58%. Total Assets is also linked to Revenue through Asset Turnover. Nexalis Therapeutics's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Nexalis Therapeutics  (ASX:NX1) Total Assets Explanation

Total Assets is connected with ROA %.

Nexalis Therapeutics's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-1.528/( (1.436+1.208)/ 2 )
=-1.528/1.322
=-115.58 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Nexalis Therapeutics's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (1.436+1.208)/ 2 )
=0/1.322
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Nexalis Therapeutics Total Assets Related Terms

Nexalis Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Nexalis Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexalis Therapeutics Total Assets Chart

Nexalis Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.95 2.29 1.58 0.71 1.21

Nexalis Therapeutics Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 0.58 0.71 1.44 1.21

Nexalis Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Nexalis Therapeutics's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-1.175+2.383
=1.21

Nexalis Therapeutics's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-1.175+2.383
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of A$1.21 Mil mean?
Nexalis Therapeutics (ASX:NX1) has a Total Assets of A$1.21 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Nexalis Therapeutics and its competitors.
Is Nexalis Therapeutics' Total Assets too high?
Nexalis Therapeutics' current Total Assets is A$1.21 Mil.
How does Nexalis Therapeutics' Total Assets compare to VRTX and REGN?
Nexalis Therapeutics' Total Assets of A$1.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Nexalis Therapeutics and its competitors. Nexalis Therapeutics's current Total Assets is A$1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexalis Therapeutics stock overvalued right now?
Nexalis Therapeutics (ASX:NX1) has a current Total Assets of A$1.21 Mil. The current Total Assets is A$1.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Nexalis Therapeutics (ASX:NX1), the current Total Assets is A$1.21 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexalis Therapeutics Business Description

Address 505 Little Collins Street, Level 9, Melbourne, VIC, AUS, 3000
Nexalis Therapeutics Ltd is an Australian clinical-stage drug development company that is focused on developing therapies to address unmet medical needs in pain management and mental health sectors. Its pipeline includes three clinical drug candidates focused on treatment-resistant depression (SRX-25), breakthrough cancer pain (IRX-211), and panic disorder (IRX-616a), each addressing areas of unmet medical need and potential commercial demand.